In NASH rats, two-week treatment of SV (NS) and GJ (NG1) significantly reduced the serum ALT (42.46 and 47.34%), AST (69.65 and 66.98%), LDL/vLDL (75.21 and 58.36%), and TC (58.95 and 48.27%) levels compared to the treatment of vehicle (NC) (Figure 5B). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.